The University of Chicago Header Logo

Connection

Peter H. O'Donnell to Drug Screening Assays, Antitumor

Back to Details
This is a "connection" page, showing publications Peter H. O'Donnell has written about Drug Screening Assays, Antitumor.
Peter H. O'Donnell
Connection Strength
0.034
Drug Screening Assays, Antitumor
  1. Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients. Oncotarget. 2016 Jun 21; 7(25):38359-38366.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.